Skip to main content
Clinical Trials/NCT04941066
NCT04941066
Completed
Not Applicable

Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination

Laureate Institute for Brain Research, Inc.1 site in 1 country44 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Laureate Institute for Brain Research, Inc.
Enrollment
44
Locations
1
Primary Endpoint
Changes in Brooding subscale of Ruminative Responses Scale (RRS) scores
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to assess the feasibility and efficacy of real-time fMRI neurofeedback for rumination.

Detailed Description

Neuroimaging MRI techniques for measuring brain structure, tissue composition, and Blood Oxygenation Level Dependent functional Magnetic Resonance imaging (BOLD fMRI) will be used to measure task-dependent and task-independent brain hemodynamic and electrophysiological changes in human subjects with major depressive disorders (MDD). After being informed about the study and potential risks, all participants giving written informed consent will undergo one session of the cognitive process-based fMRI neurofeedback (CNF) targeting the rumination-related brain functional connectivity, and a one-week follow-up. Participants will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to Active (receiving feedback from their own brain activity) or Sham (receiving artificially generated feedback).

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
March 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Good general health
  • DSM-5 diagnosis of major depressive disorder (MDD)

Exclusion Criteria

  • General Exclusion Criteria:
  • Pregnancy
  • Medical Conditions:
  • Moderate to severe traumatic brain injury (\>30 min. loss of consciousness or \>24 hours posttraumatic amnesia) or other neurocognitive disorder with evidence of neurological deficits.
  • Presence of co-morbid medical conditions not limited to but including cardiovascular (e.g., history of acute coronary event, stroke) and neurological diseases (e.g., Parkinson's disease), as well as pain disorders.
  • Presence of an uncontrolled medical condition that is deemed by the investigators to interfere with the proposed study procedures, or to put the study participant at undue risk.
  • Psychiatric Disorders:
  • Current severe suicidal ideation or attempt within the past 12 months.
  • Psychosis
  • Bipolar disorder

Outcomes

Primary Outcomes

Changes in Brooding subscale of Ruminative Responses Scale (RRS) scores

Time Frame: Through study completion (average: 2 weeks)

The RRS Brooding subscale is a self-report scale to measure brooding ruminative responses. A higher score indicates higher brooding ruminative responses with a maximum score of 20 and a minimum score of 5.

Functional connectivity change between precuneus and right temporoparietal junction (rTPJ)

Time Frame: Through study completion (average: 2 weeks)

Functional connectivity between precuneus and rTPJ will be calculated and evaluated using fMRI BOLD percent signal change.

Secondary Outcomes

  • Changes in sum of Brooding and Depression subscales of Ruminative Responses Scale (RRS) scores(Through study completion (average: 2 weeks))
  • Changes in total score of Ruminative Responses Scale (RRS) scores(Through study completion (average: 2 weeks))
  • Changes in Depression subscale of Ruminative Responses Scale (RRS) scores(Through study completion (average: 2 weeks))
  • Changes in Reflection subscale of Ruminative Responses Scale (RRS) scores(Through study completion (average: 2 weeks))

Study Sites (1)

Loading locations...

Similar Trials